Conditions: Hypertension Coronary Artery Disease
Keywords: carvedilol Coreg (TM) hypertension blood pressure coronary artery disease Nebivolol BYSTOLIC (TM)
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 39
Healthy volunteers: no

Brief summary:
This study is being done to see if the blood pressure lowering effect of an approved drug nebivolol is comparable to that of another approved drug carvedilol for the treatment of hypertension in patients who have coronary artery disease.

Detailed description:

Arms:
arm 1: Encapsulated Nebivolol arm 2: Encapsulated Carvedilol

Interventions: intervention 1: Nebivolol intervention 2: Carvedilol
Intervention descriptions: intervention 1: Encapsulated Nebivolol 5 mg, 10 mg, 20, mg, 40 mg total daily dosage, oral administration once daily intervention 2: Encapsulated Carvedilol 12.5 mg, 25 mg, 50 mg total daily dosage, oral administration twice daily

Protocol document: